Judge: Edward M. Chen Case No.: 3:19-cv-02573-EMC Time: 1:30-1:48 18 minutes Case Name: In re HIV Antitrust Litigation Attorneys for Plaintiffs: Michael Roberts, Erich Schork, Morgan Hunt Attorneys for Defendant: Deputy Clerk: Vicky Ayala Court Reporter: Kendra Steppler

For the reasons stated on the record, the DPPs’ motion for disbursement of funds is granted.

There is no need to give the class notice of the motion in light of the relatively small size of the funds at issue.

At the hearing, the DPPs provided additional information in support of the request for disbursement – e.g., explaining that Dr. Lamb’s office spent more than 300 hours on distribution- related work due to issues related to complexities in the assignments of interests and the different groups of drug claims at issue.

Finally, at the hearing, the DPPs provided some explanation as to why there was a delay in the distribution of funds (which were held in an interest-bearing account).

KPH Healthcare Services, Inc. v. Gilead Sciences, Inc. et al., 3:20-cv-06961-EMC Case No. 3:19-cv-02573-EMC (lead case)

Having considered the Direct Purchaser Class Plaintiffs’ Motion to Disburse BMS Settlement Funds for BMS Settlement Administration Expenses, filed by KPH Healthcare Services, Inc. a/k/a Kinney Drugs, Inc., on behalf of itself and the BMS DPP Settlement Class, the Court GRANTS the motion and ORDERS the Escrow Agent, Computershare Trust Company, N.A., to disburse from the BMS Settlement Fund:

to reimburse Dr. Lamb for expenses incurred in administering the BMS Settlement, in the amount of $131,721.50; and to reimburse KCC for expenses incurred in administering the BMS Settlement, in an amount not to exceed $30,669.89.

The Honorable Edward M. Chen United States District Judge

KPH Healthcare Services, Inc. v. Gilead Sciences, Inc. et al., 3:20-cv-06961-EMC Case No. 3:19-cv-02573-EMC (lead case)

Having considered the Direct Purchaser Class Plaintiffs’ Motion to Disburse BMS Settlement Funds for BMS Settlement Administration Expenses, filed by KPH Healthcare Services, Inc. a/k/a Kinney Drugs, Inc., on behalf of itself and the BMS DPP Settlement Class, the Court GRANTS the motion and ORDERS the Escrow Agent, Computershare Trust Company, N.A., to disburse from the BMS Settlement Fund:

to reimburse Dr. Lamb for expenses incurred in administering the BMS Settlement, in the amount of $131,721.50; and to reimburse KCC for expenses incurred in administering the BMS Settlement, in an amount not to exceed $30,669.89.

The Honorable Edward M. Chen United States District Judge

At a Stated Term of the United States Court of Appeals for the Second Circuit, held at the Thurgood Marshall United States Courthouse, 40 Foley Square, in the City of New York, on the 13th day of May, two thousand twenty-four.

Corp., J M Smith Corporation, on behalf of itself and all others similarly situated, DBA Smith Drug Company, KPH Healthcare Services, Inc., individually and on behalf of all others similarly situated also known as Kinney Drugs, Inc, Mayor and City Council of Baltimore, UFCW local 1500 Welfare Fund, Teamsters Western Region & Local 177 Health Care Plan, Fraternal Order Of Police Miami Lodge 20, Insurance Trust Fund, Law Enforcement Health Benefits, Inc., Teamsters Local No. 1150 Prescription Drug Benefit Plan, Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Albertsons Companies, Inc., H-E-B L.P., The Kroger Co., Walgreen Co., Plaintiffs- Appellants,

Forest Laboratories Inc., Forest Laboratories Ireland, LTD, Forest Laboratories Holdings Ltd., Forest Laboratories, LLC, Allergan Sales LLC, Allergan, Inc., Allergan USA, Inc., Abbvie Inc., Watson Pharma, Inc., Watson Laboratories, Inc. (NY), Watson Laboratories, Inc. (CT), Watson Pharmaceuticals, Inc., Actavis, Inc., Teva Pharmaceuticals USA, Inc., Torrent Pharmaceuticals Ltd., Torrent Pharma Inc., Amerigen Pharmaceuticals Ltd., AmerigenPharmaceuticals Inc., Glenmark Generics Inc.,

6/4/2024 Case 23-410, Document 302-1, 06/04/2024, 3625224, Page2 of 2 USA, Glenmark Generics Ltd., Glenmark Pharmaceuticals S.A., Hetero Labs Ltd, Hetero Drugs LTD., Hetero USA Inc., Indchemie Health Specialties Private Ltd., Alkem Laboratories Ltd., Ascend Laboratories, LLC, ANI Pharmaceuticals, Inc., Watson Laboratories, Inc. (NV), Watson Laboratories, Inc. (DE), Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Defendants - Appellees.

IT IS HEREBY ORDERED, ADJUDGED and DECREED that the district court’s judgment dismissing Plaintiff’s claims with prejudice is AFFIRMED.